Search clinical trials for: Atomoxetine (Strattera)
Total 200 results
-
Massachusetts General HospitalEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderSpain, France, Austria, Germany, Belgium, Finland, Italy, Netherlands, Portugal, Sweden, Switzerland, United Kingdom
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA)TerminatedMethamphetamine Dependence | Methamphetamine AbuseUnited States
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
Craig HospitalCompletedTraumatic Brain INjuryUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Yale UniversityTerminatedCocaine Dependence | Opiate DependenceUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderItaly
-
Yale UniversityVA Office of Research and DevelopmentWithdrawnNicotine DependenceUnited States
-
University of PennsylvaniaEli Lilly and CompanyCompletedMenopause | Cognitive DisturbancesUnited States
-
Denver Health and Hospital AuthorityAmerican Academy of Child Adolescent Psychiatry.CompletedAttention Deficit Hyperactivity Disorder | Substance AbuseUnited States
-
RWTH Aachen UniversityCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderChina, Taiwan, Korea, Republic of
-
University of PittsburghStanley Medical Research InstituteCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of, China, Taiwan
-
Eli Lilly and CompanyCompletedAttention Deficit Disorder With HyperactivityItaly
-
Medical University of South CarolinaMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's Disease | Cognitive ImpairmentUnited States
-
Eli Lilly and CompanyTerminatedAttention Deficit Hyperactivity Disorder | Cannabis AbuseNetherlands
-
University of Maryland, BaltimoreNational Heart, Lung, and Blood Institute (NHLBI)CompletedType 1 DiabetesUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed
-
University of California, San DiegoEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAutistic Disorder | Attention Deficit Disorder With HyperactivityNetherlands
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderGermany
-
Johns Hopkins UniversityEli Lilly and CompanyCompleted
-
University of CincinnatiNational Institute of Mental Health (NIMH)UnknownAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas Southwestern Medical CenterNational Institute of Mental Health (NIMH); Stanley Medical Research InstituteCompletedCognition in SchizophreniaUnited States
-
VA Office of Research and DevelopmentCompletedAttention Deficit Hyperactivity Disorder | Post Traumatic Stress DisorderUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of
-
Icahn School of Medicine at Mount SinaiCompletedMultiple Sclerosis | Memory DisordersUnited States
-
Lumy SawakiCompletedAtomoxetine Hydrochloride | Placebos
-
Yale UniversityNational Alliance for Research on Schizophrenia and DepressionCompletedSmoking | Schizophrenia | CognitionUnited States
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed
-
Vanderbilt University Medical CenterCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderAustralia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
-
University of IowaEli Lilly and CompanyCompleted
-
University of California, Los AngelesCompletedMethamphetamine Dependence in Remission | Continuous Methamphetamine Dependence
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderAustralia, United Kingdom, Mexico
-
Massachusetts General HospitalEli Lilly and CompanyCompleted
-
Research Foundation for Mental Hygiene, Inc.Eli Lilly and CompanyCompletedSchizophreniaUnited States
-
Emory UniversityNational Institute on Aging (NIA)CompletedMild Cognitive ImpairmentUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderItaly, Spain, France, Belgium, Turkey, Ireland, Mexico, Norway, United Kingdom
-
Vanderbilt University Medical CenterNYU Langone HealthCompletedNeurogenic Orthostatic HypotensionUnited States
-
University of ArkansasNational Institute on Drug Abuse (NIDA)CompletedMethamphetamine DependenceUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Attention Deficit Disorder With HyperactivityUnited States
-
University of Colorado, BoulderNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Center...TerminatedAlcohol Craving | Mood ChangesUnited States